Corbion Nv · EURONEXT:CRBN
Corbion Nv — Q1 2026 Earnings Presentation
11 slides from Corbion Nv's earnings presentation, Apr 22, 2026
Slide 1: Q1 2026 Results
Q1 2026 RESULTS OLIVIER RIGAUD (CEO) PETER KAZIUS (CFO) 22-Apr-2026
Slide 2: Forward-looking statements disclaimer
Q1 2026 RESULTS This presentation contains forward-looking statements with respect to Corbion’s future performance and position. Such statements are based on current expectations, estimates, and projections of Corbion and information currently available to the company. Corbion cautions readers that
Slide 3: Key Results
Q1 2026 RESULTS Key Results Organic sales growth • Sales of € 293.7 million • Organic sales growth of -4.1% -4.1% • Volume/mix -2.6% & Pricing -1.5% • Adjusted EBITDA € 37.8 million, Adjusted EBITDA margin 12.9% Adj EBITDA margin • Functional Ingredients & Solutions: resilient underlying volumes in
Slide 4: Sales and Adjusted EBITDA: Q1 2026
Q1 2026 RESULTS Sales and Adjusted EBITDA: Q1 2026 € million Q1 2026 Q1 2025 Growth Sales - Functional Ingredients & Solutions 236.0 257.0 -8.2% - Health & Nutrition 57.7 72.7 -20.6% Total Sales 293.7 329.7 -10.9% Adjusted EBITDA - Functional Ingredients & Solutions 21.3 31.0 -31.3% - Health & Nutri
Slide 5: Sales growth per segment: Q1 2026
Q1 2026 RESULTS Sales growth per segment: Q1 2026 Sales growth Vol./mix Price Organic Currency Acq./Div. Total Q1 2026 vs Q1 2025 - Functional Ingredients & Solutions +0.1% -0.9% -0.8% -7.4% 0.0% -8.2% - Health & Nutrition -11.8% -4.0% -15.8% -4.8% 0.0% -20.6% Total -2.6% -1.5% -4.1% -6.8% 0.0% -10.
Slide 6: Sales and Adjusted EBITDA development
Q1 2026 RESULTS Sales and Adjusted EBITDA development Sales Adjusted EBITDA Organic Total Organic Total € million -4.1% -10.9% € million -19.7% -30.5% 329.7 60 330 2.1 54.4 320 11.5 316.1 50 10.7 43.7 310 40 5.9 37.8 22.4 300 293.7 30 290 10 10 0 0 Sales FI&S H&N Organic Forex Sales Adjusted Organic
Slide 7: Functional Ingredients & Solutions
Q1 2026 RESULTS Functional Ingredients & Solutions Organic sales growth (%) Q1 Organic Sales growth -0.8%, matching strong Q1-2025 level Functional Ingredient & Solutions 5.8 - Volume/mix: +0.1% - Price -0.9% • Food: Growth in natural preservation, prices mildly up, soft US-market conditions 0.8 0 •
Slide 8: Health & Nutrition
Q1 2026 RESULTS Health & Nutrition Org sales growth (%) Health & Nutrition 24.9 Q1 Organic Sales decline of -15.8% 16.2 - Volume/mix: -11.8% - Price: -4.0% • The temporary decline in volume/mix growth was primarily attributable to the Nutrition, -0.6 as well as the Pharma business. -11.2 • Biomateri
Slide 9: TotalEnergies Corbion Joint Venture
Q1 2026 RESULTS TotalEnergies Corbion Joint Venture Organic sales (€m) TotalEnergies Corbion JV Organic Sales growth of +2.9% • Continuous recovery of volume Adjusted EBITDA margin 5.3% (-250 bps vs LY) • Margin contraction vs LY driven by price dynamics Q1-25 Q2-25 Q3-25 Q4-25 Q1-26 The process to
Slide 10: FY 2026 outlook affirmed
Q1 2026 RESULTS FY 2026 outlook affirmed Organic sales growth +3-6% Adjusted EBITDA margin ~ 17% Free Cash Flow* € 85-90 million • Capex spend 2026-2028: ~6% of sales 10 22-Apr-2026 * Free Cash Flow = Cash Flow from operating activities -/- Cash Flow from investment activities (excluding acquisition
Slide 11: Investor relations
Investor relations alex.sokolowski@corbion.com www.corbion.com +31 20 590 6341